{"id":"dactavira-plus","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug combines antiviral agents that target different steps of the hepatitis C virus lifecycle, likely including NS5B polymerase and/or protease inhibitors. By hitting multiple viral targets simultaneously, the combination approach aims to improve efficacy and reduce the risk of resistance development in hepatitis C patients.","oneSentence":"Dactavira Plus is a direct-acting antiviral combination therapy designed to inhibit hepatitis C virus replication through multiple viral targets.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:34.118Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hepatitis C virus infection (genotype unspecified)"}]},"trialDetails":[{"nctId":"NCT03186313","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection","status":"COMPLETED","sponsor":"Egyptian Liver Hospital","startDate":"2016-09","conditions":"Hepatitis C","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Dactavira Plus","genericName":"Dactavira Plus","companyName":"Egyptian Liver Hospital","companyId":"egyptian-liver-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dactavira Plus is a direct-acting antiviral combination therapy designed to inhibit hepatitis C virus replication through multiple viral targets. Used for Hepatitis C virus infection (genotype unspecified).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}